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Does laparoscopic donor nephrectomy
put pediatric recipients at risk?
Laparoscopic donor nephrectomy (LDN) was
first described in 1995 (1). The technique was
quickly adopted by many transplant programs
and by 2000, half of the living donor nephrecto-
mies for adult recipients were being performed
laparoscopically (2). Concerned there was more
enthusiasm than science behind this trend, we
conducted the first prospective randomized trial
comparing LDN with open donor nephrectomy
(ODN) and demonstrated conclusive benefits to
the donor with respect to post-operative recovery
(3). Outcomes for the LDN adult recipients were
comparable as well, though this study was not
powered to examine this endpoint. Over the
years, multiple large series have been published.
While some early series reported higher rates of
delayed graft function (DGF) and ureteral com-
plications, the majority of reports have suggested
potential benefits to the donor and equivalent
outcomes for the recipient compared with ODN.
A review of the OPTN/UNOS database of adult
kidney recipients transplanted between Novem-
ber 1999 and December 2000 suggested that
LDN was associated with similar rates of DGF,
acute rejection and one yr graft survival com-
pared with ODN (4). This report also noted that
LDN was associated with slower early graft
function, though this conclusion is based on a
slightly higher discharge creatinine in the LDN
recipients who left the hospital slightly earlier
than the ODN group. Subsequently, a systematic
review of 44 published series, nearly all focusing
on adult recipients, concluded the LDN and
ODN were similar with respect to short-term
donor and recipient outcomes in the adult
population (5). From the recipients perspective,
at least, the issue seems resolved in adult trans-
plantation.
While LDN was quickly embraced as the new
standard for adult recipients, there have been
concerns regarding the impact on outcomes for
pediatric recipients. This largely centers on the
decrease in renal blood flow observed with the
pneumoperitoneum in LDN (6, 7), and how this
could adversely interact with the potential rela-
tive hypoperfusion of the adult size kidney in the
pediatric recipient (8, 9). These concerns are
especially relevant in the smallest pediatric
recipients, where such physiologic events could
lead to higher rates of DGF, graft thrombosis,
and graft loss. Independent of graft loss, reduc-
tion in renal blood flow following reperfusion
could generate non-specific damage that might
increase the risk for subsequent immunologically
and non-immunologically mediated injury and
therefore compromise graft survival over the
long term.
Adoption of the LDN approach for pediatric
recipients has lagged behind the adult recipient
population. Nonetheless, by 2003, 66% of the
donor procedures were LDN (2). Initial reports
from several centers suggested that outcomes
following LDN for pediatric recipients were
equivalent to ODN (10–12). More reports have
followed, providing additional evidence of reci-
pient equivalent outcomes (13–17). While some
suggest that initial graft function, as measured by
serum creatinine, is somewhat delayed compared
with the ODN group (11), none have demon-
strated an impact on long-term outcomes. In
these series, the rates of surgical complications,
DGF, acute rejection, and graft survival all
appear equivalent.
While single center studies are reassuring,
these reports only reflect a small number of
children, and are underpowered to evaluate
many of the issues. A review of the OPTN/
UNOS database by Troppmann and colleagues
evaluated outcomes for LDN and ODN in
pediatric recipients transplanted between Janu-
ary 2000 and June 2002. During this time, 44%
of the donor nephrectomies for recipients five yr
of age or less, and 50% of those for recipients
age six–18 yr, were reported as LDN. In the 212




youngest children (five yr of age and below),
LDN was associated with a fivefold higher
(12.8% vs. 2.5%) risk of delayed graft function
and a threefold higher (18.6% vs. 5.9%) risk of
acute rejection in the first six months. There was
a slightly less impressive but still statistically
significant higher rate of DGF (5.9% vs. 2.8%)
and acute rejection (22.5% vs. 15.6%) associated
with LDN in the older pediatric recipients as
well. Graft survival at one and two yr, however,
was equivalent in both age ranges. In the
multivariate analysis performed, LDN was an
independent risk factor for acute rejection. Based
on these findings, there were calls for caution
and consideration for a prospective randomized
trial of LDN vs. ODN in small pediatric
recipients (18).
How does one reconcile this analysis with the
single center reports? While this registry analysis
adjusted for many factors, there are other vari-
ables such donor relation and center effects
including surgical management, perioperative
care, and immunosuppression regimens which
were not accounted for. Additionally, LDN was
less common in pediatrics transplantation over-
all, and in the younger children in particular,
potentially reflecting a center effect or practice
pattern. Is there a reporting bias? Are the rates of
DGF and ACR in the ODN group representa-
tive? Dissecting these issues is difficult with
registry analysis.
In the current issue of this journal, Dave et al.
report a series of 11 children who underwent
LDN transplant, and compare them with the 11
preceding children who underwent ODN trans-
plant (19). Understanding that the hypothesis
underpinning much of the concern for the use of
LDN for pediatric recipients centers on the
impact of LDN on graft blood flow, they
performed blinded intra-operative Doppler ultra-
sound assessment of the allograft following
reperfusion. They found no difference in the
mean intra-operative resistive index (RI) between
the LDN and ODN group (0.66 vs. 0.59,
respectively). Additionally none of the LDN
kidneys had an abnormal RI, as defined as
RI < 0.5 or >0.8, whereas three children in the
ODN group had abnormal RIs. Of note, the
three recipients less than five yr of age in
the LDN group all had normal intra-operative
RIs. While the authors are to be commended for
their attempts to address the proximal mecha-
nism of concern, i.e., renal blood flow, there are
still questions. Perhaps the greatest issue is that
one could posit that the changes in renal blood
flow attributable to LDN would occur several
hours following reperfusion rather than intra-
operatively. Indeed, as pointed out by the
authors, Raiteri et al. demonstrated that abnor-
mal RIs at 24 h were associated with DGF and
barring technical vascular issues, intra-operative
RIs are often normal even in patients who go on
to develop DGF (20). A Doppler evaluation at
24 h in the current report would be instructive.
Regardless of this shortcoming, Dave et al. noted
no difference in serum creatinine, DGF, acute
rejection, and graft survival between the two
groups, adding to the handful of other single
center reports.
Is the collective experience sufficient to exclude
the possibility that LDN does not disproportion-
ately impact the risk for the smallest recipients?
There are fewer reports addressing this issue but
there is evidence equivalent results can be
obtained. The series by Singer et al. included
nine LDN and five ODN recipients aged five yr
or less and reported similar outcomes (15). We
have subsequently updated our experience, and
in a sub-analysis focusing on 10 LDN recipients
less than 20 kg, these small recipients had equiv-
alent creatinine clearance at five days and one-yr
post-transplant, similar rates of acute rejection,
and equivalent graft survival at one and three yr
compared with 11 matched ODN recipients (21).
Will a randomized trial evaluating the impact of
LDN in small pediatric recipients ever be con-
ducted? It seems unlikely. To detect a twofold
increase in the rate of DGF (assuming an
expected incidence of 2–4%) a randomized trial
would need several hundred patients in each
group. Over the last decade in the US, there have
been approximately 100 living donor transplants
performed annually in recipient less than six yr of
age (22). More importantly, a registry analysis
that does not account for a center effect (2) does
not provide sufficient rationale for such a trial in
the face of all the published literature. LDN is
also clearly the current standard in the United
States. In 2007, 91% of all living donors had
LDN (23). The rate of LDN has also increased
for pediatric recipients, and the difference in rates
between the smaller and larger children is
diminishing. From 2004 to 2007, 73.7% of living
donors for recipients age five yr of age or less,
and 76.2% in the six–17 yr age range, were LDN.
LDN is a mature procedure that should be
offered to donors. Indeed, it is possible that in a
few more years, ODN may represent a higher
risk procedure for both recipients and donors
based on lack of experience with the procedure.
Does LDN place the pediatric recipient at risk?
The answer is of course yes. All surgical proce-
dures, indeed all medical interventions, place
patients at risk. Transplantation is unique in that
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outcomes can be impacted by components of two
operations. Is the risk of LDN greater than that
associated with ODN? It should not be. Any type
of donor nephrectomy performed poorly can
compromise graft survival. It is clear that at
many programs, equivalent outcomes can be
obtained using LDN. LDN must be done by
experienced surgeons and performed well. There
are important surgical aspects of LDN which
must be given proper consideration, including
proper volume loading of the donor, degree and
duration of pneomoperitoneum, and gentle dis-
section and manipulation to minimize vaso-
spasm. One must pay careful and ongoing
attention to recipient outcomes. If one loses
sight of these principles, results will suffer. All
these points are equally valid with ODN.
What will keep the debate going? Is right sided
LDN or LDN for a kidney with two arteries
contraindicated for pediatric recipients? Are
outcomes better with hand-assisted LDN or
totally laparoscopic LDN? Again the guiding
principle for both donors and recipients is to do
the best operation possible, but there is no reason
in 2008 that LDN is not the preferred approach,
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